Rivastigmine in the treatment of dementia associated with Parkinson's disease: effects on activities of daily living.

Abstract:

AIMS:To investigate the effects of rivastigmine capsule 3-12 mg/day over 24 weeks on activities of daily living (ADLs) in patients with dementia associated with Parkinson's disease (PDD). METHODS:Post hocanalysis of a prospective, multicenter, randomized, double-blind, placebo-controlled trial in patients with PDD (>or=50 years) randomized to rivastigmine 3-12 mg/day (capsules bid) or placebo over 24 weeks. This analysis was carried out with three subscales derived from a factor analysis of the 23 items in the Alzheimer's Disease Cooperative Study - Activities of Daily Living (ADCS-ADL) scale. These subscales were basic ADLs (10 items), high-level function ADLs (eight items) and autonomy ADLs (five items). RESULTS:541 patients were randomized (362 to rivastigmine, 179 to placebo) and 410 (75.8%) completed the study. Rivastigmine was associated with significantly better outcomes in basic ADLs (-0.5 +/- 6.19 vs. -1.7 +/- 5.46; p = 0.025; effect size 22.1%) and high-level function ADLs (0.1 +/- 4.95 vs. -1.0 +/- 4.49; p = 0.017; effect size 22.9%) compared with placebo, at week 24. CONCLUSION:In patients with PDD, treatment with rivastigmine may show beneficial effects on overall ADLs, as well as modest, statistically significant improvements in basic ADLs and high-level function ADLs.

authors

Olin JT,Aarsland D,Meng X

doi

10.1159/000305100

subject

Has Abstract

pub_date

2010-01-01 00:00:00

pages

510-5

issue

6

eissn

1420-8008

issn

1421-9824

pii

000305100

journal_volume

29

pub_type

杂志文章,多中心研究,随机对照试验
  • Lifestyle Factors and Subjective Cognitive Impairment in Patients Seeking Help at a Memory Disorder Clinic: The Role of Negative Life Events.

    abstract:BACKGROUND/AIMS:A large proportion of patients at memory disorders clinics are classified as having subjective cognitive impairment (SCI). Previous research has investigated whether particular lifestyle factors known to affect cognition can be useful in differentiating patients who do not show objective evidence of mem...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000505573

    authors: Andersson C,Marklund K,Walles H,Hagman G,Miley-Akerstedt A

    更新日期:2019-01-01 00:00:00

  • Association Study and Meta-Analysis of Polymorphisms, Methylation Profiles, and Peripheral mRNA Expression of the Serotonin Transporter Gene in Patients with Alzheimer's Disease.

    abstract:BACKGROUND/AIM:The aim of this study was to elucidate the relationship between Alzheimer's disease (AD) and the serotonin transporter gene (SLC6A4). METHODS:AD subjects (n = 43) and controls (n = 47) were recruited and evaluated. In leukocytes, we evaluated two polymorphisms in SLC6A4, the serotonin transporter length...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章,meta分析

    doi:10.1159/000447324

    authors: Yamazaki K,Yoshino Y,Mori T,Okita M,Yoshida T,Mori Y,Ozaki Y,Sao T,Iga J,Ueno S

    更新日期:2016-01-01 00:00:00

  • Memory for performed actions in dementia of Alzheimer type: further evidence for a global semantic memory deficit.

    abstract::Findings in patients with dementia of the Alzheimer type (AD patients) concerning the enactment effect, i.e. reaching a better memory performance after encoding actions by performing them in contrast to encoding them by reading, are ambiguous. In order to get more insight into memory deterioration in patients sufferin...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000089135

    authors: Mack W,Eberle C,Frölich L,Knopf M

    更新日期:2005-01-01 00:00:00

  • Risk factors of transition from normal cognition to mild cognitive disorder: the PATH through Life Study.

    abstract:AIMS:The aim of this study was to identify physical and mental health and lifestyle predictors of transition from normal cognition to mild cognitive disorder (MCD). METHODS:A total of 2,082 individuals, aged 60-64 years, were assessed at 2 time-points 4 years apart for mild cognitive impairment (MCI) and other MCDs. ...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000229025

    authors: Cherbuin N,Reglade-Meslin C,Kumar R,Jacomb P,Easteal S,Christensen H,Sachdev P,Anstey KJ

    更新日期:2009-01-01 00:00:00

  • Executive function and activities of daily living in Alzheimer's disease: a correlational meta-analysis.

    abstract:BACKGROUND:The assessment of executive function (EF) and activities of daily living (ADL) are important elements in the diagnosis of Alzheimer's disease. METHODS:Following a comprehensive search in three databases, a random-effects meta-analysis was used to investigate the association between ADL ability and seventeen...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章,meta分析

    doi:10.1159/000338233

    authors: Martyr A,Clare L

    更新日期:2012-01-01 00:00:00

  • Korean version of the Baylor Profound Mental Status Examination: a brief staging measure for patients with severe Alzheimer's disease.

    abstract:BACKGROUND:The Baylor Profound Mental Status Examination (BPMSE) was modeled to provide a brief patient-derived rating scale for staging and tracking patients with severe stages of Alzheimer's disease (AD). METHODS:The BPMSE was administered to 91 patients with probable AD (Korean version of the MMSE less than 16) acc...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000192585

    authors: Na HR,Lee SH,Lee JS,Doody RS,Kim SY

    更新日期:2009-01-01 00:00:00

  • Clinical validity of the Mattis Dementia Rating Scale in differentiating mild cognitive impairment in Parkinson's disease and normative data.

    abstract:BACKGROUND/AIMS:The aim of the present study was to provide normative data and determine the validity of the Czech version of the Mattis Dementia Rating Scale 2 (czDRS-2) in screening for mild cognitive impairment in Parkinson's disease (PD-MCI) based on the Movement Disorder Society (MDS) Level II criteria. METHODS:F...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000375365

    authors: Bezdicek O,Michalec J,Nikolai T,Havránková P,Roth J,Jech R,Růžička E

    更新日期:2015-01-01 00:00:00

  • High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study.

    abstract:BACKGROUND/AIMS:The aim of the study was to investigate the association of postoperative delirium with the outcomes of cognitive impairment, functional disability and death. METHODS:Hip surgery patients aged 60 years or over (n = 200) underwent preoperative and daily postoperative assessment of their cognitive status ...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000140804

    authors: Bickel H,Gradinger R,Kochs E,Förstl H

    更新日期:2008-01-01 00:00:00

  • Predictors of Clinical Progression of Subjective Memory Impairment in Elderly Subjects: Data from the Clinical Research Centers for Dementia of South Korea (CREDOS).

    abstract:BACKGROUND/AIMS:The aims of this study were to determine baseline factors related to the progression of subjective memory impairment (SMI) in elderly subjects and to develop a new modeling scale to predict progression. METHODS:Elderly subjects with SMI were recruited from the nationwide Clinical Research Centers for D...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000430807

    authors: Hong YJ,Yoon B,Shim YS,Kim SO,Kim HJ,Choi SH,Jeong JH,Yoon SJ,Yang DW,Lee JH

    更新日期:2015-01-01 00:00:00

  • Subtle attentional deficits in the absence of dementia are associated with an increased risk of post-operative delirium.

    abstract:BACKGROUND:Previously, key studies of the risk profile for post-surgical delirium have focused on general medical and non-elective patients, few have examined elective cohorts. Accurate prediction is imperative for clinical trials and prevention strategies. AIMS/HYPOTHESIS:Our hypothesis was that subtle pre-operative ...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000101453

    authors: Lowery DP,Wesnes K,Ballard CG

    更新日期:2007-01-01 00:00:00

  • Cognitive impairment related to apathy in early Huntington's disease.

    abstract:OBJECTIVE:To investigate the relationships between cognitive impairment and apathy in patients with early Huntington's disease (HD) and to further explore the influence of depression on the outcome of cognitive changes associated with apathy. METHODS:We included 36 early HD patients, among them 20 were apathetic (HDA)...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000091523

    authors: Baudic S,Maison P,Dolbeau G,Boissé MF,Bartolomeo P,Dalla Barba G,Traykov L,Bachoud-Lévi AC

    更新日期:2006-01-01 00:00:00

  • Apolipoprotein E ε4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis.

    abstract:BACKGROUND:The ε4 allele of apolipoprotein E (APOE) is associated with Alzheimer's disease (AD). However, attributable risk due to APOE4 varies by region and by race/ethnicity. METHODS:A literature review and meta-analysis were conducted to estimate the prevalence of APOE4 by geographic area among AD patients. RESULT...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章,meta分析,评审

    doi:10.1159/000321984

    authors: Crean S,Ward A,Mercaldi CJ,Collins JM,Cook MN,Baker NL,Arrighi HM

    更新日期:2011-01-01 00:00:00

  • Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors.

    abstract::Mild cognitive impairment (MCI) is regarded as a precursor to dementia, but not all patients with MCI develop dementia. We followed up 165 elderly outpatients with MCI for a mean of 3 years. The aims were (1) to investigate the risk of conversion to dementia for different MCI subtypes diagnosed according to standardiz...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000089515

    authors: Ravaglia G,Forti P,Maioli F,Martelli M,Servadei L,Brunetti N,Pantieri G,Mariani E

    更新日期:2006-01-01 00:00:00

  • The Role of Gait Speed in Dementia: A Secondary Analysis from the SABE Colombia Study.

    abstract:INTRODUCTION:Gait speed (GS) is a predictor of negative outcomes in older adults and in those in risk to develop cognitive impairment; as such, it has been associated with dementia. Studies in Latin-American older adults showing this association are scarce. This study aimed to evaluate the relationship between GS and d...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000510494

    authors: Garcia-Cifuentes E,Márquez I,Vasquez D,Aguillon D,Borda MG,Lopera F,Cano-Gutierrez C

    更新日期:2020-11-18 00:00:00

  • Comparative effects of ageing and dementia of the Alzheimer type on orientation of visual attention.

    abstract::Age-related changes and the effects of dementia of the Alzheimer type (DAT) were investigated during a visual orienting attention task in which attention was pre-cued to one or other hemifields. Central cues were either valid, neutral, invalid or NoGo (inhibitory). The response time cost-benefit analysis showed a decr...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000106657

    authors: Wright M,Geffen G,Geffen L

    更新日期:1997-11-01 00:00:00

  • Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease.

    abstract:AIMS:Mild cognitive impairment (MCI) usually represents a transitional phase between normal cognitive function and dementia, but not all people with MCI develop dementia because MCI is a clinically and etiologically heterogeneous grouping. The aim of this study was to compare progression rates to Alzheimer's disease (A...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000339159

    authors: Lee YM,Park JM,Lee BD,Moon E,Chung YI,Kang CJ

    更新日期:2012-01-01 00:00:00

  • Gross anatomy of the corpus callosum in Alzheimer's disease: regions of degeneration and their neuropsychological correlates.

    abstract:BACKGROUND/AIMS:Differences in the gross shape of the corpus callosum (CC) and its subregional areas were investigated on brain MRI of patients with probable Alzheimer's disease (AD) and age- and gender-matched healthy normal control subjects. The AD patients differed from the normal control subjects in terms of a more...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000097371

    authors: Tomaiuolo F,Scapin M,Di Paola M,Le Nezet P,Fadda L,Musicco M,Caltagirone C,Collins DL

    更新日期:2007-01-01 00:00:00

  • Galantamine versus risperidone for agitation in people with dementia: a randomized, twelve-week, single-center study.

    abstract:AIMS:To examine the effects of galantamine and risperidone on agitation in patients with dementia. METHODS:A total of 100 patients with dementia and neuropsychiatric symptoms (mean age ± SD: 78.6 ± 7.5 years; 67% female) were included in this 12-week, randomized, parallel-group, controlled, single-center trial. The pa...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章,随机对照试验

    doi:10.1159/000362204

    authors: Freund-Levi Y,Bloniecki V,Auestad B,Tysen Bäckström AC,Lärksäter M,Aarsland D

    更新日期:2014-01-01 00:00:00

  • Pharmacology of Alzheimer's disease: appraisal and prospects.

    abstract::Ten years after the introduction of the first drug, tacrine, in the treatment of Alzheimer's disease, it seems appropriate to re-appraise the pharmacological processes of innovation in the research field of dementia. The aim of this review is to pinpoint concrete improvements achieved in this field, regarding experime...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章,评审

    doi:10.1159/000084400

    authors: Sellal F,Nieoullon A,Michel G,Michel BF,Lacomblez L,Geerts H,Delini Stula A,Bordet R,Bentué-Ferrer D,Allain H

    更新日期:2005-01-01 00:00:00

  • Polymorphisms of fas gene: relationship with Alzheimer's disease and cognitive decline.

    abstract::The Fas antigen (CD95) is a cell surface receptor that mediates cell apoptosis signalling. Recent investigations have shown that Fas-regulated apoptosis was linked to neurodegenerative lesions in the brain of patients with Alzheimer's disease (AD). Here data regarding the association of two polymorphisms of the Fas pr...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000095160

    authors: Chiappelli M,Nasi M,Cossarizza A,Porcellini E,Tumini E,Pinti M,Troiano L,Franceschi M,Licastro F

    更新日期:2006-01-01 00:00:00

  • Nature versus nurture in frontotemporal lobar degeneration: the interaction of genetic background and education on brain damage.

    abstract:BACKGROUND:Frontotemporal lobar degeneration (FTLD) is a progressive neurodegenerative disorder with a strong genetic background. It has been reported that modifiable factors, i.e. education (E), might act as proxies for reserve capacity. OBJECTIVE:To evaluate the impact of genetic background (positive family history,...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000339366

    authors: Premi E,Garibotto V,Alberici A,Paghera B,Giubbini R,Padovani A,Borroni B

    更新日期:2012-01-01 00:00:00

  • Patients with Alzheimer's disease may be particularly susceptible to adverse effects of statins.

    abstract::In epidemiological, cross-sectional studies, treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) prevented to a large extent the development of Alzheimer's disease (AD), but the results of randomized, placebo-controlled studies, focused on statin therapy in patients with ischemic heart ...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章,评审

    doi:10.1159/000076342

    authors: Algotsson A,Winblad B

    更新日期:2004-01-01 00:00:00

  • Evaluation of the quality of life in dementia with a generic quality of life questionnaire: the Duke Health Profile.

    abstract:OBJECTIVE:The study was designed to determine the acceptability, feasibility and validity of measuring quality of life in a representative sample of dementia patients with a generic instrument, the Duke Health Profile. METHOD:The French version of the Duke Health Profile was administered to 148 subjects with a mental ...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000051251

    authors: Novella J,Ankri J,Morrone I,Guillemin F,Jolly D,Jochum C,Ploton L,Blanchard F

    更新日期:2001-03-01 00:00:00

  • Determinants of quality of life in nursing home residents with dementia.

    abstract:AIMS:The goal of this study is to assess the relationship between quality of life (QoL), neuropsychiatric symptoms (NPS), psychotropic drug use (PDU) and patient characteristics in a large group of nursing home residents with dementia. METHODS:This cross-sectional observational study included 288 individuals with deme...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000280437

    authors: Wetzels RB,Zuidema SU,de Jonghe JF,Verhey FR,Koopmans RT

    更新日期:2010-01-01 00:00:00

  • Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease.

    abstract::We investigated regional cerebral glucose metabolic rates (rCMRgluc) with positron emission tomography using 2-[18F]fluoro-2-deoxy-D-glucose (FDG) in 7 monozygotic twin pairs discordant for Alzheimer's disease (AD). Ten healthy volunteers with comparable mean age and educational level served as controls. In the hippoc...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000072809

    authors: Järvenpää T,Räihä I,Kaprio J,Koskenvuo M,Laine M,Kurki T,Vahlberg T,Viljanen T,Ahonen K,Rinne JO

    更新日期:2003-01-01 00:00:00

  • The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients.

    abstract::Accumulating evidence suggests that butyrylcholinesterase (BuChE) plays an important role in the progression of cognitive deficits and Alzheimer-type pathology in dementia patients. We examined the relationship between the K variant of BuChE and the severity of deposits of amyloid (Abeta(1-42)) and phosphorylated tau ...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000084705

    authors: Ballard C,Morris C,Kalaria R,McKeith I,Perry R,Perry E

    更新日期:2005-01-01 00:00:00

  • A SPECT study of sleep disturbance and Alzheimer's disease.

    abstract:BACKGROUND/AIMS:This study aimed to investigate the possible association of regional cerebral perfusion and sleep loss in Alzheimer's disease (AD). METHODS:55 AD patients were characterized as having (SL) or not having (NSL) nocturnal sleep loss based on standard AD scales assessing sleep over the previous 4 weeks. (9...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000203889

    authors: Ismail Z,Herrmann N,Francis PL,Rothenburg LS,Lobaugh NJ,Leibovitch FS,Black SE,Lanctôt KL

    更新日期:2009-01-01 00:00:00

  • Serum lipids are related to Alzheimer's pathology in nursing home residents.

    abstract:BACKGROUND:Studies of associations between serum lipids and Alzheimer's disease (AD) or other dementias in the elderly show conflicting results, perhaps due to misclassification of the various dementias. METHODS:For 358 nursing home residents, serum lipids were studied at admission and diagnoses established at autopsy...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000189268

    authors: Lesser GT,Haroutunian V,Purohit DP,Schnaider Beeri M,Schmeidler J,Honkanen L,Neufeld R,Libow LS

    更新日期:2009-01-01 00:00:00

  • Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia.

    abstract::The two most frequently examined biomarkers in the diagnosis of dementia are cerebrospinal fluid (CSF) tau and beta-amyloid(1-42) (Abeta(1-42)). An assay for tau phosphorylated at threonine 181 (phospho-tau) has recently been developed. We studied these three markers in patients with possible Alzheimer's disease (AD; ...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000066023

    authors: Nägga K,Gottfries J,Blennow K,Marcusson J

    更新日期:2002-01-01 00:00:00

  • Report about four novel mutations in the prion protein gene.

    abstract:BACKGROUND/AIMS:Since detection of the prion protein gene (PRNP) more than 30 mutations have been discovered. Some have only been found in single case reports without known intrafamilial accumulation or neuropathological proof so that the causal connection between mutation and disease could not be proved. Those patient...

    journal_title:Dementia and geriatric cognitive disorders

    pub_type: 杂志文章

    doi:10.1159/000345991

    authors: Schelzke G,Stoeck K,Eigenbrod S,Grasbon-Frodl E,Raddatz LM,Ponto C,Kretzschmar HA,Zerr I

    更新日期:2013-01-01 00:00:00